Abivax SA (2X1) Financial Statements

4 Followers

Abivax SA Financial Overview

Abivax SA's market cap is currently €8.09B. The company's EPS TTM is €-1.04; its P/E ratio is -8.89; Abivax SA is scheduled to report earnings on March 23, 2026, and the estimated EPS forecast is €-0.81. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Mar 24	Dec 22	Dec 21
Income Statement
Total Revenue	€ 0.00	€ 10.79M	€ 4.62M	€ 4.58M	€ 37.00K
Gross Profit	€ -1.07M	€ 10.79M	€ 4.49M	€ 4.51M	€ -119.00K
Operating Income	€ -250.63M	€ -185.43M	€ -127.38M	€ -64.84M	€ -52.19M
EBITDA	€ -249.55M	€ -167.68M	€ -133.21M	€ -53.31M	€ -42.20M
Net Income	€ -336.10M	€ -176.24M	€ -147.74M	€ -60.74M	€ -42.45M
Balance Sheet
Cash & Short-Term Investments	€ 530.38M	€ 144.22M	€ 260.99M	€ 26.95M	€ 60.70M
Total Assets	€ 584.34M	€ 205.23M	€ 327.06M	€ 73.35M	€ 110.36M
Total Debt	€ 32.09M	€ 97.36M	€ 55.46M	€ 39.16M	€ 53.45M
Net Debt	€ -484.59M	€ -46.86M	€ -196.48M	€ 19.78M	€ -7.25M
Total Liabilities	€ 129.14M	€ 164.64M	€ 131.05M	€ 71.47M	€ 81.59M
Stockholders' Equity	€ 455.20M	€ 40.58M	€ 196.01M	€ 7.19M	€ 25.93M
Cash Flow
Free Cash Flow	€ -162.23M	€ -154.72M	€ -97.39M	€ -69.55M	€ -47.30M
Operating Cash Flow	€ -162.09M	€ -154.07M	€ -97.13M	€ -65.58M	€ -45.66M
Investing Cash Flow	€ -13.72M	€ 15.76M	€ -8.10M	€ -3.73M	€ -1.46M
Financing Cash Flow	€ 553.80M	€ 28.21M	€ 335.29M	€ 32.21M	€ 82.68M

Currency in EUR

Abivax SA Earnings and Revenue History

Income Statement >

Abivax SA Debt to Assets

Balance Sheet >

Abivax SA Cash Flow

Cash Flow >

Abivax SA Forecast EPS vs Actual EPS

Earnings >